Delaware ranks 3rd highest per capita in health-care spending, with per capita health-care costs more than 27 percent above the U.S. average, behind only Alaska and Massachusetts. In response, in February 2018, Governor John Carney (D) signed an executive order to form an advisory group to set a benchmark that would help slow the state’s rising health care costs. The executive order comes five months after the passage of HJR 7 that gave DHSS authority to establish a benchmark that would link the growth rate of health-care spending to the state’s rate of economic growth.
In the 2017-2018 legislative session, Delaware introduced several legislation aimed at controlling prescription drug costs. Most notably, the legislature passed HB 425, a legislation that prevents pharmacist gag clause and allows substitution of therapeutically equivalent drugs to provide lower-cost alternatives for consumers.
2020 Legislative Session: 1/14/2020 - 1/21/2021 (2019-2020 term). *Current session bill updates are ongoing. Check back weekly for updates.
Delaware operates on an annual budget cycle. The governor submits a proposed budget by February 1 to the state legislature, and a budget is passed by June 30. The fiscal year begins on July 1 and ends on June 30 the following year.
REGULATION & ENFORCEMENT
- Delaware was one of 16 states to file an amicus brief supporting the FTC’s winning position in the Ninth Circuit appeal of St. Luke’s Health Care Sys. v. FTC, No. 14-35173 (March 7, 2014), decided February 10, 2015. The States’ brief stated that the acceleration of health care costs due to the growth of large health care provider systems had become a matter of grave concern for the states.
- Delaware State Legislature
- Delaware Office of the Attorney General
- Delaware Office of Management and Budget